ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025
[German pharmacy degree course: an international comparison].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A theoretically informed interview study of strategic stakeholders on their readiness to implement a pharmacist competency framework for hospital practice.International journal of clinical pharmacy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While a pharmacy degree in Germany uses a state examination system, they are divided into three university education systems worldwide: Master of Science (MSc), Master of Pharmacy (MPharm), and Doctor of Pharmacy (PharmD). The educational content of the German pharmacy degree and state examination is dictated by the "Approbationsordnung für Apotheker" (AAppO) and focuses on pharmaceutical sciences. Shaped by the Bologna Process, the MSc is an academic degree that focuses on advanced studies and research in a specific area of pharmaceutical sciences or related fields. The MPharm and PharmD degrees, which have become established in the Anglo-American region, offer primarily clinical training to prepare pharmacists for complex tasks in an interdisciplinary team. New technologies, scientific progress, and global challenges have an important influence on the content of pharmacist education, which is taken on board at very different speeds. While in many countries the subject-specific content and the achievement of uniformly defined competencies are ensured by accreditation bodies, the course content in countries like Germany does not allow any greater scope for redesign, which is due to rigid legal frameworks and educational policy fragmentation. Although the pharmacy degree is a highly qualifying process, there is an urgent need for European curricula to be more in line with the expectations of a modern pharmacist role profile. This narrative review examines the different university education systems and the driving factors for the further development of the pharmaceutical curriculum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.